Interleukin-4 PE38KDEL cytotoxin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-4 PE38KDEL cytotoxin, covering 2013-07-18 to 2013-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]